home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 20, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 551 active entries

Genome Explorations A Division Of Compass Lab Services

1910 Nonconnah Blvd. Suite 120
Memphis 38132
United States of America, Tennessee

Phone: 901 578 5708
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

Clinical Diagnostics

Genome Explorations is an Industry Leader in Providing Complete range of Molecular Diagnostic (MDx) Services to Clinical Institutes Worldwide. Our State of the art CLIA Certified GLP compliant laboratories utilize the latest Next Generation (NextGen) Sequencing from ThermoFisher, Life Technologies and the Gold standard Affymetrix Microarray Platforms to provide unsurpassed clinical diagnostic services. Over the past 12 Years Genome Explorations Research Labs have be instrumental in developing the Next Generation of Molecular Cancer diagnostics (MDx) and now our clinical labs enable Physicians to treat their patients with the utmost confidence. In Addition to Cancer Diagnostics, our Scientists are working with researchers worldwide to develop NextGen sequencing panels for Pharmacogenomics, Cardiovascular, Arrhythmia, Cardiomyopathy and Hereditary disorders.

 

 

Genomic Services

Our experienced scientists work one-on-one with Scientists, Researchers and Clinicians to provide a ‘Complete Solution’ for Genotyping, Gene Expression and miRNA Profiling Genomic Services from experimental design to in-depth data analysis and advanced bioinformatics. Genome Explorations also offers ‘Complete Solutions’ using the Life Technologies Affymetrix GeneChip Platformfor challenging specimens, such as whole blood and FFPE tissues.  With over 50 years of combined experience, our scientists at Genome Explorations have developed detailed standard operating procedures (SOP’s) that allow us to consistently generate the highest quality, most reproducible data sets in the industry. Genome Explorations has received global acknowledgements for their achievements, and has been the industry leader in Providing Complete Genomics Solutions since 2001.

Contract Research

Genome Explorations provides both high throughout service and comprehensive research project execution. Genome Explorations scientists and affiliates represent some of the most skilled clinical, molecular and bioinformatic researchers in USA. Our Scientists have conducted varying clinical projects aimed at finding signatures, drug targets or genotypes defined by Pharma/Biotech customers. Genome Explorations is a market leader in Biomarker Discovery, Companion Diagnostics, Novel Drug Screening and Clinical Validation programs.



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Diagnostics
- in vitro
- Medical
Pharmaceutical
- Research
Contract
- Research
- Services

Last update of this entry: June 14, 2016

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.